Filing Flows › Regeneron Pharmaceuticals (REGN) › Other revenue revenue
Regeneron Pharmaceuticals (REGN) Other revenue revenue by quarter
Regeneron Pharmaceuticals' Other revenue revenue was $310M in Q3 2026 (third quarter 2026), +60% from Q2 2026. Over the last 7 quarters it ranged from $81.9M (Q1 2025) to $310M (Q3 2026).
| Quarter | Other revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $310M | +60% | +56% |
| Q2 2026 | $193M | +13% | +5% |
| Q1 2026 | $171M | -28% | +109% |
| Q4 2025 | $239M | +20% | — |
| Q3 2025 | $198M | +8% | — |
| Q2 2025 | $184M | +125% | — |
| Q1 2025 | $81.9M | — | — |
Q3 2026 at a glance
Regeneron Pharmaceuticals, Q3 2026: revenue $5.1B (+36% year over year), operating margin 40.0%, net earnings $1.9B, operating cash flow $1.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is Regeneron Pharmaceuticals' Other revenue revenue?
Regeneron Pharmaceuticals' Other revenue revenue was $310M in Q3 2026 (third quarter 2026), +60% from Q2 2026.
How has Regeneron Pharmaceuticals' Other revenue revenue changed?
Over the last 7 quarters it ranged from $81.9M (Q1 2025) to $310M (Q3 2026).
Q3 2026 results → · How Regeneron Pharmaceuticals makes money →